Infective endocarditis with negative blood cultures

International Journal of Antimicrobial Agents

Volumn 30, Issue SUPPL. 1, 2007, Pages 32-36

  Naber, Christoph K ^a   Erbel, Raimund ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Endocarditis; Gentamicin; Negative bloodcultures; Staphylococcus aureus

Indexed keywords

DALFOPRISTIN PLUS QUINUPRISTIN; FLUCLOXACILLIN; GENTAMICIN; LINEZOLID; OXACILLIN; PENICILLIN G; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL ENDOCARDITIS; BARTONELLA; BLOOD CULTURE; CHLAMYDOPHILA PSITTACI; COXIELLA BURNETII; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; STANDARDIZATION; STAPHYLOCOCCUS AUREUS;

BACTERIA; BLOOD; ENDOCARDITIS, BACTERIAL; HUMANS; POLYMERASE CHAIN REACTION;

EID: 34848926236     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2007.07.017     Document Type: Article

References (44)

1. Tunkel A.R., and Kaye D. Endocarditis with negative blood cultures. N Engl J Med 326 (1992) 1215-1217
2. Lamas C.C., and Eykyn S.J. Blood culture negative endocarditis: analysis of 63 cases presenting over 25 years. Heart 89 (2003) 258-262
3. Hogevik H., Olaison L., Andersson R., Lindberg J., and Alestig K. Epidemiologic aspects of infective endocarditis in an urban population. A 5-year prospective study. Medicine (Baltimore) 74 (1995) 324-339
4. Werner M., Andersson R., Olaison L., and Hogevik H. A clinical study of culture-negative endocarditis. Medicine (Baltimore) 82 (2003) 263-273
5. Sandre R.M., and Shafran S.D. Infective endocarditis: review of 135 cases over 9 years. Clin Infect Dis 22 (1996) 276-286
6. Hoen B., Alla F., Selton-Suty C., et al., Association pour l'Etude et la Prevention de l'Endocardite Infectieuse (AEPEI) Study Group. Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA 288 (2002) 75-81
7. Benetka O., Block M., Sangha O., et al., On behalf of the ALKK. Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausärzte. Clinical course of infective endocarditis in the late nineties: preliminary results of the ALKK endocarditis registry. Eur Heart J 20 suppl (1999) 362 [abstract]
8. Krcmery V., Gogova M., Ondrusova A., et al., Slovak Endocarditis Study Group. Etiology and risk factors of 339 cases of infective endocarditis: report from a 10-year national prospective survey in the Slovak Republic. J Chemother 15 (2003) 579-583
9. Tariq M., Alam M., Munir G., Khan M.A., and Smego Jr. R.A. Infective endocarditis: a five-year experience at a tertiary care hospital in Pakistan. Int J Infect Dis 8 (2004) 163-170
10. Murashita T., Sugiki H., Kamikubo Y., and Yasuda K. Surgical results for active endocarditis with prosthetic valve replacement: impact of culture-negative endocarditis on early and late outcomes. Eur J Cardiothorac Surg 26 (2004) 1104-1111
11. Abraham A.K., Neutze J.M., MacCulloch D., and Cornere B. Culture negative infective endocarditis. Aust N Z J Med 14 (1984) 223-226
12. Pesanti E.L., and Smith I.M. Infective endocarditis with negative blood cultures. An analysis of 52 cases. Am J Med 66 (1979) 43-50
13. Hoen B., Selton-Suty C., Lacassin F., et al. Infective endocarditis in patients with negative blood cultures: analysis of 88 cases from a one-year nationwide survey in France. Clin Infect Dis 20 (1995) 501-506
14. Durack D.T., Lukes A.S., and Bright D.K. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med 96 (1994) 200-209
15. Rognon R., Kehtari R., and Francioli P. Individual value of each of the Duke criteria for the diagnosis of infective endocarditis. Clin Microbiol Infect 5 (1999) 396-403
16. Lamas C.C., and Eykyn S.J. Suggested modifications to the Duke criteria for the clinical diagnosis of native valve and prosthetic valve endocarditis: analysis of 118 pathologically proven cases. Clin Infect Dis 25 (1997) 713-719
17. Li J.S., Sexton D.J., Mick N., et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 30 (2000) 633-638
18. Fournier P.E., Casalta J.P., Habib G., Messana T., and Raoult D. Modification of the diagnostic criteria proposed by the Duke Endocarditis Service to permit improved diagnosis of Q fever endocarditis. Am J Med 100 (1996) 629-633
19. Raoult D., Casalta J.P., Richet H., et al. Contribution of systematic serological testing in diagnosis of infective endocarditis. J Clin Microbiol 43 (2005) 5238-5242
20. Brouqui P., and Raoult D. New insight into the diagnosis of fastidious bacterial endocarditis. FEMS Immunol Med Microbiol 47 (2006) 1-13
21. Goldenberger D., Kunzli A., Vogt P., Zbinden R., and Altwegg M. Molecular diagnosis of bacterial endocarditis by broad-range PCR amplification and direct sequencing. J Clin Microbiol 35 (1997) 2733-2739
22. Millar B., Moore J., Mallon P., et al. Molecular diagnosis of infective endocarditis-a new Duke's criterion. Scand J Infect Dis 33 (2001) 673-680
23. Grijalva M., Horvath R., Dendis M., Erny J., and Benedik J. Molecular diagnosis of culture negative infective endocarditis: clinical validation in a group of surgically treated patients. Heart 89 (2003) 263-268
24. Gauduchon V., Chalabreysse L., Etienne J., et al. Molecular diagnosis of infective endocarditis by PCR amplification and direct sequencing of DNA from valve tissue. J Clin Microbiol 41 (2003) 763-766
25. Bosshard P.P., Kronenberg A., Zbinden R., Ruef C., Bottger E.C., and Altwegg M. Etiologic diagnosis of infective endocarditis by broad-range polymerase chain reaction: a 3-year experience. Clin Infect Dis 37 (2003) 167-172
26. Rothman R.E., Majmudar M.D., Kelen G.D., et al. Detection of bacteremia in emergency department patients at risk for infective endocarditis using universal 16S rRNA primers in a decontaminated polymerase chain reaction assay. J Infect Dis 186 (2002) 1677-1681
27. Zeaiter Z., Fournier P.E., Greub G., and Raoult D. Diagnosis of Bartonella endocarditis by a real-time nested PCR assay using serum. J Clin Microbiol 41 (2003) 919-925
28. Branger S., Casalta J.P., Habib G., Collard F., and Raoult D. Streptococcus pneumoniae endocarditis: persistence of DNA on heart valve material 7 years after infectious episode. J Clin Microbiol 41 (2003) 4435-4437
29. Lang S., Watkin R.W., Lambert P.A., Littler W.A., and Elliott T.S. Detection of bacterial DNA in cardiac vegetations by PCR after the completion of antimicrobial treatment for endocarditis. Clin Microbiol Infect 10 (2004) 579-581
30. Rovery C., Greub G., Lepidi H., et al. PCR detection of bacteria on cardiac valves of patients with treated bacterial endocarditis. J Clin Microbiol 43 (2005) 163-167
31. Naber CK, Neuerburg C, Plicht B, Erbel R. Clin Res Cardiol 2007; Suppl: 1435 [abstract].
32. Baddour L.M., Wilson W.R., Bayer A.S., et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications. Circulation 111 (2005) e394-e434
33. Horstkotte D., Follath F., Gutschik E., et al. Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European society of cardiology. Eur Heart J 25 (2004) 267-276
34. Naber C.K., Bauhofer A., Block M., et al. S2 Guideline for diagnosis and therapy of infectious endocarditis. Z Kardiol 93 (2004) 1005-1021
35. Fowler Jr. V.G., Miro J.M., Hoen B., et al. ICE Investigators. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 293 (2005) 3012-3021
36. Stevens D.L. The role of vancomycin in the treatment paradigm. Clin Infect Dis 42 Suppl 1 (2006) S51-S57
37. Fowler Jr. V.G., Sanders L.L., Sexton D.J., et al. Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients. Clin Infect Dis 27 (1998) 478-486
38. Eurosurveillance 2006, 11: 060413 [incomplete/page span].
39. Falagas M.E., Manta K.G., Ntziora F., and Vardakas K.Z. Linezolid for the treatment of patients with endocarditis: a systematic review of the published evidence. J Antimicrob Chemother 58 (2006) 273-280
40. Fowler Jr. V.G., Boucher H.W., Corey G.R., et al. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med 355 (2006) 653-665
41. Korzeniowski O., and Sande M.A. Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: a prospective study. Ann Intern Med 97 (1982) 496-503
42. Paul M., Silbiger I., Grozinsky S., Soares-Weiser K., and Leibovici L. Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis. Cochrane Database Syst Rev (2006) CD003344
43. Falagas M.E., Matthaiou D.K., and Bliziotis I.A. The role of aminoglycosides in combination with a beta-lactam for the treatment of bacterial endocarditis: a meta-analysis of comparative trials. J Antimicrob Chemother 57 (2006) 639-647
44. Aksoy O., Sexton D.J., Wang A., et al. Early surgery in patients with infective endocarditis: a propensity score analysis. Clin Infect Dis 44 (2007) 364-372